AXQ Capital’s Oculis Holding OCS Stock Holding History

AXQ Capital’s Portfolio OCS Stock Details OCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,118	Closed	-$375K	–	1243
2026 Q1	$375K	Buy	+14,118	New	+$374K	0.05%	516

Other funds holding OCS

EFM

EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

AXQ Capital's OCS Position: Q2 2026 in Review

AXQ Capital sold out of Oculis Holding (OCS) in Q2 2026, closing a stake of 14,118 shares — an estimated $375K sold.

AXQ Capital first reported a position in OCS in Q1 2026 and held it in 1 quarter. The position peaked at $375K in Q1 2026. 59 funds tracked by Wall St. Rank hold OCS as of Q2 2026.

AXQ Capital reported no remaining Oculis Holding position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 14,118 Oculis Holding shares in Q2 2026, an estimated $375K.
AXQ Capital first reported a position in Oculis Holding in Q1 2026 and held it in 1 quarter.
AXQ Capital's Oculis Holding position peaked at $375K in Q1 2026.
59 funds tracked by Wall St. Rank held Oculis Holding as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.